Bringing Clinical Trials to Life

Pediatrics

Pediatric trials run the gamut of indications in drug development, but they all have primary things in common – working with children and their families requires specialized expertise and deep knowledge of regulatory requirements….
More...

Dermatology

Together, Cu-Tech and Synteract create the leading dermatology CRO, with global capabilities and unparalleled access to sites and patients. Our focus on novel and required dermatology drugs provides dedicated research services unmatched in the market.
More...

Oncology

Like our clients, we are committed to the quest to cure cancer. But cancer is not just a single disease. It takes deep trial knowledge to know how to address its many forms. Learn how Synteract has stayed ahead of the trends leading towards new treatments…
More...

Neuro Degenerative

Neuro degenerative disorders are some of the most confounding and complex to affect people. Our specialized experience in these trials aids you in developing treatments that improve functioning and help the lives of both patients and caregivers…
More...

Rare & Orphan Diseases

Rare and orphan diseases have unique characteristics, not the least of which is finding the right population for your trials. We know the investigators and study sites that can help to address your recruitment goals, among other challenges…
More...

11/27/2018 - 11/29/2018 : Dermatology Drug Development Summit More...

11/15/2018: Synteract has acquired KinderPharm, a specialty pediatric CRO, focused on advancing pediatric drug development across all phases of clinical research. More ...

11/14/2018: Expanding Site Selection to Quality Sites Synteract Participates on MAGI Panel on Advancing Site Selection - Site selection is a critical aspect of successful clinical trials. Sponsors and CROs are often drawn to known sites with which they have strong working relationships and that are good performers and enrollers.

Synteract Blog 

11/16/2018: Meet our Pediatric Development team of experts. Each individual has a profound, logistical understanding of the pediatric drug development industry, that’s essential when working with children and their families. Learn how our team can collaborate with you on your #pediatric clinical trial: http://ow.ly/f90Q50jHLvx

Synteract on LinkedIn

11/15/2018: We have acquired #pediatric #CRO KinderPharm. This acquisition further strengthens our pediatric capabilities and p… https://t.co/cHin1XayVZ

Synteract Twitter Feed
x

Contact Synteract

Tell us how to stay in touch with you:

*Required